Remember meForgot password?
    Log in with Twitter

article imageIntravenous nutritional product recalled

By Tim Sandle     Jan 8, 2014 in Health
Pharma company Baxter International Inc. has initiated a recall in the U.S. of two lots of injectable nutrition products due to complaints of particulate matter found in the products.
According to the U.S. Food and Drug Administration (FDA), the affected products are premixed sterile intravenous nutrition products that come in multi-chambered containers. The products are used as a caloric component and as a protein source in a nutrition program. The product is called CLIMIX.
The reason for the recall is because, if infused, particulate matter may result in blockages of blood vessels, which can result in stroke, heart attack, or damage to other organs such as the kidney or liver. In Baxter’s press release it is noted that there is also the possibility of allergic reactions, local irritation, and inflammation in tissues and organs. However, there have been no reported adverse events associated with this issue to date.
The affected product codes, Medical Web Times notes, are: 2B7729 (lot P287045, exp 06/14), 2B7717 (lot P275883, exp 10/13) and 2B7709 (lot P285122, exp 05/14). Affected products were distributed to healthcare centers and distributors in the U.S.
The Digital Journal has highlighted a number of significant pharmaceutical product recalls over the past 12 months. These can be found here.
More about Recall, Fda, Drug, Nutrition
More news from
Latest News
Top News